The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995–2005

BACKGROUND: The use of genotyping to distinguish recrudescent from new infections is currently recommended for all clinical antimalarial efficacy trials by the World Health Organization. However, genotyping-adjusted drug efficacy estimates may vary between trials due to the use of different genotypi...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, William J, Greenhouse, Bryan, Rosenthal, Philip J, Dorsey, Grant
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716173/
https://www.ncbi.nlm.nih.gov/pubmed/17169157
http://dx.doi.org/10.1186/1475-2875-5-122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716173/
https://www.ncbi.nlm.nih.gov/pubmed/17169157
http://dx.doi.org/10.1186/1475-2875-5-122

Ejemplares similares